CLASS II Drug recall · Reported 6 Apr 2022 · FDA Enforcement Report
Testosterone Cypionate/ Dhea *GS* 200/10MG/ML Injectable recalled
Drug Depot Inc is recalling Testosterone Cypionate/ Dhea *GS* 200/10MG/ML Injectable, distributed nationwide in the US. The recall was initiated on 23 Mar 2022 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0732-2022
- FDA event ID
- 89808
- Recalling firm
- Drug Depot Inc, Palm Harbor, FL
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 23 Mar 2022
- FDA classified
- 29 Mar 2022
- Reported
- 6 Apr 2022
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 23 Mar 2022 | Recall initiated by company | |
| 29 Mar 2022 | Classified by FDA | +6 days |
| 6 Apr 2022 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of sterility assurance.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi dose 10ML vial, as a) 5 ML Formula ID 115678; b) 10 ML Formula ID 115498, APS Pharmacy
Where it was distributed
Nationwide in the USA including Puerto Rico.
Questions about this recall
Why was it recalled?
Lack of sterility assurance.
Which lots are affected?
Lots: a)746000 BUD: 6/26/2022; b) 751472 BUD: 7/20/2022
Where was it sold?
Nationwide in the USA including Puerto Rico.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
7 other products · FDA event 89808This product is part of a recall event; the main page for the event is Testosterone Cypionate/ Anastrozole *gs* Oil 200mg/0.5mg/ML recalled.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Testosterone Cypionate/ Anastrozole *gs* Oil 200mg/0.5mg/ML recalled | Drug Depot Inc | Sterility | Nationwide | |
| CLASS II | Gonadorelin 0.2 MG/ML Injectable recalled by Drug Depot, Inc | Drug Depot Inc | Sterility | Nationwide | |
| CLASS II | Testosterone Cypionate/Propionate *Ses* Oil 160MG/20MG/ML Injectable recalled | Drug Depot Inc | Sterility | Nationwide | |
| CLASS II | Testosterone Cypionate *GS* 80 MG/ML Injectable recalled | Drug Depot Inc | Sterility | Nationwide | |
| CLASS II | Testosterone Cypionate *GS* Oil 200 MG/ML Injectable recalled | Drug Depot Inc | Sterility | Nationwide | |
| CLASS II | Testosterone Cypionate/Anastrozole *GS* Oil 200MG/1MG/ML Injectable recalled | Drug Depot Inc | Sterility | Nationwide | |
| CLASS II | (ca) Gonadorelin 0.2 MG/ML Injectable recalled by Drug Depot, Inc | Drug Depot Inc | Sterility | Nationwide |
More recalls from Drug Depot Inc
All 8| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | (ca) Gonadorelin 0.2 MG/ML Injectable recalled by Drug Depot, Inc | Drug Depot Inc | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate/Anastrozole *GS* Oil 200MG/1MG/ML Injectable recalled | Drug Depot Inc | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate *GS* Oil 200 MG/ML Injectable recalled | Drug Depot Inc | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate *GS* 80 MG/ML Injectable recalled | Drug Depot Inc | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate/Propionate *Ses* Oil 160MG/20MG/ML Injectable recalled | Drug Depot Inc | Sterility | Nationwide |
Other Testosterone Cypionate recalls
All 130| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Testosterone Cypionate Injection, 200 mg/mL, CIII recalled | Empower Clinic Services | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate Injection, USP, CIII, 200mg per mL recalledTestosterone Cypionate | Eugia US | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Testosterone Cypionate Injection, USP, CIII, 200 mg/mL recalledTestosterone Cypionate | Azurity Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Testosterone Cypionate/Enanthate 100/100mg/ml, a)-vial recalled | TMC Acquisition | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate/Anastrozole 200mg/1mg/mL, a)-vial recalled | TMC Acquisition | Sterility | Nationwide |